title: Inadequacy of mucosal IgM antibodies in selective IgA deficiency: excretion of attenuated polio viruses is prolonged.
abstract: A nationwide vaccination campaign with oral poliovirus vaccine was organized in Finland in 1985 in order to cease an outbreak of poliomyelitis. We followed eight IgA-deficient individuals and nine controls for poliovirus excretion in feces and for antibody responses in serum and saliva. Five weeks after oral poliovirus vaccination all eight IgA-deficient individuals were still excreting polioviruses, in contrast to one of nine controls. The concentration of polioviruses, as estimated by a semi-quantitative immunofluorescent assay, was generally higher and the test was significantly more often positive in the samples from the IgA-deficient individuals. Although serum levels of antibodies to poliovirus type 3 were lower in IgA-deficient individuals before vaccination, both measurements showed that the two groups had similar antibody levels 4 weeks after vaccination. IgA-deficient individuals lacked salivary IgA antibodies to poliovirus types 1 and 3 but had increased levels of IgM antipolio antibodies, which were shown to carry secretory component. We conclude that the mucosal IgM antibodies of IgA-deficient individuals eliminate polioviruses less efficiently than do the IgA antibodies of normal individuals.
authors.affiliation: Children's Hospital, University of Helsinki, Finland.
authors.forename: E
authors.initials: E
authors.lastname: Savilahti
authors.forename: T
authors.initials: T
authors.lastname: Klemola
authors.forename: B
authors.initials: B
authors.lastname: Carlsson
authors.forename: L
authors.initials: L
authors.lastname: Mellander
authors.forename: M
authors.initials: M
authors.lastname: Stenvik
authors.forename: T
authors.initials: T
authors.lastname: Hovi
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D004406:Dysgammaglobulinemia / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005243:Feces / Q000382:microbiology; D005455:Fluorescent Antibody Technique; D006801:Humans; D017098:IgA Deficiency; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000276:immunology*; D009092:Mucous Membrane / Q000276:immunology; D017955:Poliovirus / Q000302:isolation & purification; D011055:Poliovirus Vaccine, Oral / Q000276:immunology*; D012463:Saliva / Q000276:immunology; D013997:Time Factors
chemical_list: D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011055:Poliovirus Vaccine, Oral